Episode Details
Back to Episodes
Biogen Advances Tau-Targeting Drug in Alzheimer's Fight
Published 2 days, 8 hours ago
Description
Biogen Advances Tau-Targeting Alzheimers Drug to Phase Three: Despite Mixed Mid-Stage Results, Low Dose Shows Promise
Support the show:
Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:
advertise@thednn.ai
This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.
View sources & latest updates:
https://sources.thednn.ai/24142c8fe31aac48